CHF135.60 intraday 19 Jan 2026: UBXN.SW stock near 50-day average, watch earnings
UBXN.SW stock trades at CHF135.60 intraday on 19 Jan 2026 on the SIX exchange in Switzerland, up 0.44% on light volume (596.00). Price sits effectively at the 50-day average (CHF135.18), reflecting cautious positioning ahead of u-blox Holding AG’s next earnings on 06 Mar 2026. Investors in AI-related positioning and wireless modules are watching technical momentum and R&D spend as drivers for short-term moves. Meyka AI, an AI-powered market analysis platform, flags mixed fundamentals but model-based upside over the next quarter.
UBXN.SW stock: Intraday price action and drivers
Price opened at CHF135.00 and hit a day high of CHF135.60 with a day low of CHF135.00. Volume is light at 596.00 versus an average of 10,295.00, suggesting limited dealer flow and few headline catalysts.
The immediate driver is positioning ahead of the earnings announcement on 06 Mar 2026. With a one-year range of CHF63.00 to CHF141.40, the market has already priced a substantial recovery, but short-term moves appear tied to sector flows into Technology and wireless components.
UBXN.SW stock: Financials and valuation
u-blox reports negative EPS at -10.94 and a trailing PE of -12.39, reflecting recent losses. Price to sales is 3.95 and price to book is 23.23, indicating the market values growth and IP over current earnings.
Balance-sheet metrics look solid: current ratio 3.34, cash per share 2.03, and debt to equity 0.09. Operating margins are under pressure with operating profit margin -30.02%, driven by high R&D spend (R&D to revenue 60.22%). These figures explain the valuation premium despite weak profitability.
UBXN.SW stock: Technicals and trading signals
Momentum is neutral: RSI 52.66 and MACD histogram 0.13 show mild bullish bias. ADX at 37.44 signals a strong trend context, but Bollinger Bands (middle 135.72, upper 138.87) place price near the band center.
Short-term traders should note low relative volume (relVolume 0.06) and ATR 1.56, which suggest limited intraday range. A clear break above CHF138.87 would confirm pickup in momentum; failure to hold CHF135.00 raises the risk of re-test toward the 200-day average CHF115.84.
UBXN.SW stock: Growth, risks and sector context
Revenue per share is 5.35, but full-year revenue growth was down 54.43% year-over-year, highlighting near-term demand weakness in some end markets. Long-term opportunities remain in GNSS and AI-enabled positioning for automotive and industrial clients.
Key risks include margin pressure from heavy R&D, negative operating cash flow per share (0.13) trends, and sensitive end-market demand. Compared with the Technology sector, which shows 1M performance 5.00%, u-blox’s recovery is more idiosyncratic and tied to product cycles.
Meyka AI grade and model outlook for UBXN.SW stock
Meyka AI rates UBXN.SW with a score out of 100: 67.06 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 and sector comparison, industry metrics, financial growth, key ratios, forecasts, and analyst consensus.
Meyka AI’s forecast model projects a quarterly price of CHF158.09, a yearly price of CHF119.37, and a 3-year target of CHF132.58. The quarterly projection implies an upside of 16.58% versus the current CHF135.60, while the yearly projection implies a downside of -11.94%. Forecasts are model-based projections and not guarantees.
UBXN.SW stock: Trading strategy and practical signals
For AI-focused portfolios, consider a staged entry with stop-loss near CHF130.00 and partial profit-taking above CHF158.00 if short-term catalysts appear. Use position sizing to limit exposure given EPS and margin volatility.
Monitor upcoming earnings on 06 Mar 2026, order book updates from automotive customers, and any regulatory or supply-chain notices. Internal Meyka coverage and the u-blox press page can provide timely company-level updates.
Final Thoughts
UBXN.SW stock trades at CHF135.60 intraday on SIX with light volume and a neutral technical profile ahead of the 06 Mar 2026 earnings report. Fundamentals show strong R&D investment, a high price-to-book of 23.23, negative EPS -10.94, and a healthy current ratio 3.34, which together explain mixed analyst sentiment.
Meyka AI’s forecast model projects CHF158.09 over the next quarter (implied upside 16.58%) and CHF119.37 over the next year (implied downside -11.94%). Meyka AI rates UBXN.SW 67.06 out of 100 (Grade B, HOLD) based on sector and fundamental comparisons. These outputs suggest a risk-managed, event-driven approach: consider selective exposure ahead of earnings, watch for revenue recovery signals, and use tight sizing because valuation multiples remain elevated. Forecasts are model-based projections and not guarantees. For live company releases see u-blox press and for SIX listing details see SIX Swiss Exchange. For our live data and tracking visit the Meyka profile for UBXN.SW Meyka profile.
FAQs
What is the current UBXN.SW stock price?
As of this intraday update on 19 Jan 2026, UBXN.SW stock is trading at CHF135.60, up 0.44% on low volume (596.00). The 50-day average is CHF135.18 and the 200-day average is CHF115.84.
How does Meyka AI rate UBXN.SW stock?
Meyka AI rates UBXN.SW with a score out of 100: 67.06, Grade B, Suggestion: HOLD. The grade includes benchmark, sector, growth, key metrics, forecasts, and analyst consensus. Grades are informational, not advice.
What are Meyka AI’s price forecasts for UBXN.SW stock?
Meyka AI’s forecast model projects a quarterly target of CHF158.09 (implied upside 16.58%) and a yearly target of CHF119.37 (implied downside -11.94%). Forecasts are model-based and not guarantees.
What key risks should investors watch in UBXN.SW stock?
Key risks include negative EPS (-10.94), operating margin pressure (-30.02%), high valuation metrics like P/B 23.23, and demand sensitivity in automotive and industrial end markets. Monitor earnings and order updates.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
